Copper/zinc superoxide dismutase expression by different human osteosarcoma cell lines

Brunella Grigolo, Gina Lisignoli, Stefania Toneguzzi, Ilaria Mazzetti, Andrea Facchini

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Oxidative stress has been frequently implicated in the initiation and promotion phases of carcinogenesis. Antioxidant enzymes, which can antagonize this process, are lowered in a number of malignancies even though different findings have been reported in the literature. It has been shown that tumors have less copper/zinc superoxide dismutase (Cu/Zn SOD) in comparison with the more metabolically active tissues, but there is a large overlap between normal and tumor tissue. In order to examine the relationship between ostosarcoma at different degrees of proliferation and differentiation and Cu/ZN SOD levels, four different human osteosarcoma cell lines: HOS, U-2 OS, MG63, Saos-2 were studied for their production and release of Cu/ZN SOD. A normal human stromal cell line was used as control. Osteosarcoma cells were stimulated with TNF α, a cytokine previously shown to have antiproliferative activity. The release of Cu/ZN SOD into the supernatant was higher for the HOS and U-2 OS lines when compared to the other cell lines evaluated both in basal condition and after incubation with TNF α. Elevated intracellular levels of Cu/ZN SOD were shown except for the HOS and U-2 OS which possess high concentrations of the enzyme at 24 hours declining during the other incubation periods. These concentrations were increased after TNF α treatment. The different behaviour of the four cell lines evaluated might be explained by their degree of differentiation.

Original languageEnglish
Pages (from-to)1175-1180
Number of pages6
JournalAnticancer Research
Volume18
Issue number2 A
Publication statusPublished - Mar 1998

Fingerprint

Osteosarcoma
Superoxide Dismutase
Zinc
Copper
Cell Line
Neoplasms
Enzymes
Stromal Cells
Carcinogenesis
Oxidative Stress
Antioxidants
Cytokines

Keywords

  • Osteosarcoma cells
  • Oxgen antioxidant

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Copper/zinc superoxide dismutase expression by different human osteosarcoma cell lines. / Grigolo, Brunella; Lisignoli, Gina; Toneguzzi, Stefania; Mazzetti, Ilaria; Facchini, Andrea.

In: Anticancer Research, Vol. 18, No. 2 A, 03.1998, p. 1175-1180.

Research output: Contribution to journalArticle

Grigolo, B, Lisignoli, G, Toneguzzi, S, Mazzetti, I & Facchini, A 1998, 'Copper/zinc superoxide dismutase expression by different human osteosarcoma cell lines', Anticancer Research, vol. 18, no. 2 A, pp. 1175-1180.
Grigolo, Brunella ; Lisignoli, Gina ; Toneguzzi, Stefania ; Mazzetti, Ilaria ; Facchini, Andrea. / Copper/zinc superoxide dismutase expression by different human osteosarcoma cell lines. In: Anticancer Research. 1998 ; Vol. 18, No. 2 A. pp. 1175-1180.
@article{d129adf47bf944039b93857e050ad196,
title = "Copper/zinc superoxide dismutase expression by different human osteosarcoma cell lines",
abstract = "Oxidative stress has been frequently implicated in the initiation and promotion phases of carcinogenesis. Antioxidant enzymes, which can antagonize this process, are lowered in a number of malignancies even though different findings have been reported in the literature. It has been shown that tumors have less copper/zinc superoxide dismutase (Cu/Zn SOD) in comparison with the more metabolically active tissues, but there is a large overlap between normal and tumor tissue. In order to examine the relationship between ostosarcoma at different degrees of proliferation and differentiation and Cu/ZN SOD levels, four different human osteosarcoma cell lines: HOS, U-2 OS, MG63, Saos-2 were studied for their production and release of Cu/ZN SOD. A normal human stromal cell line was used as control. Osteosarcoma cells were stimulated with TNF α, a cytokine previously shown to have antiproliferative activity. The release of Cu/ZN SOD into the supernatant was higher for the HOS and U-2 OS lines when compared to the other cell lines evaluated both in basal condition and after incubation with TNF α. Elevated intracellular levels of Cu/ZN SOD were shown except for the HOS and U-2 OS which possess high concentrations of the enzyme at 24 hours declining during the other incubation periods. These concentrations were increased after TNF α treatment. The different behaviour of the four cell lines evaluated might be explained by their degree of differentiation.",
keywords = "Osteosarcoma cells, Oxgen antioxidant",
author = "Brunella Grigolo and Gina Lisignoli and Stefania Toneguzzi and Ilaria Mazzetti and Andrea Facchini",
year = "1998",
month = "3",
language = "English",
volume = "18",
pages = "1175--1180",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "2 A",

}

TY - JOUR

T1 - Copper/zinc superoxide dismutase expression by different human osteosarcoma cell lines

AU - Grigolo, Brunella

AU - Lisignoli, Gina

AU - Toneguzzi, Stefania

AU - Mazzetti, Ilaria

AU - Facchini, Andrea

PY - 1998/3

Y1 - 1998/3

N2 - Oxidative stress has been frequently implicated in the initiation and promotion phases of carcinogenesis. Antioxidant enzymes, which can antagonize this process, are lowered in a number of malignancies even though different findings have been reported in the literature. It has been shown that tumors have less copper/zinc superoxide dismutase (Cu/Zn SOD) in comparison with the more metabolically active tissues, but there is a large overlap between normal and tumor tissue. In order to examine the relationship between ostosarcoma at different degrees of proliferation and differentiation and Cu/ZN SOD levels, four different human osteosarcoma cell lines: HOS, U-2 OS, MG63, Saos-2 were studied for their production and release of Cu/ZN SOD. A normal human stromal cell line was used as control. Osteosarcoma cells were stimulated with TNF α, a cytokine previously shown to have antiproliferative activity. The release of Cu/ZN SOD into the supernatant was higher for the HOS and U-2 OS lines when compared to the other cell lines evaluated both in basal condition and after incubation with TNF α. Elevated intracellular levels of Cu/ZN SOD were shown except for the HOS and U-2 OS which possess high concentrations of the enzyme at 24 hours declining during the other incubation periods. These concentrations were increased after TNF α treatment. The different behaviour of the four cell lines evaluated might be explained by their degree of differentiation.

AB - Oxidative stress has been frequently implicated in the initiation and promotion phases of carcinogenesis. Antioxidant enzymes, which can antagonize this process, are lowered in a number of malignancies even though different findings have been reported in the literature. It has been shown that tumors have less copper/zinc superoxide dismutase (Cu/Zn SOD) in comparison with the more metabolically active tissues, but there is a large overlap between normal and tumor tissue. In order to examine the relationship between ostosarcoma at different degrees of proliferation and differentiation and Cu/ZN SOD levels, four different human osteosarcoma cell lines: HOS, U-2 OS, MG63, Saos-2 were studied for their production and release of Cu/ZN SOD. A normal human stromal cell line was used as control. Osteosarcoma cells were stimulated with TNF α, a cytokine previously shown to have antiproliferative activity. The release of Cu/ZN SOD into the supernatant was higher for the HOS and U-2 OS lines when compared to the other cell lines evaluated both in basal condition and after incubation with TNF α. Elevated intracellular levels of Cu/ZN SOD were shown except for the HOS and U-2 OS which possess high concentrations of the enzyme at 24 hours declining during the other incubation periods. These concentrations were increased after TNF α treatment. The different behaviour of the four cell lines evaluated might be explained by their degree of differentiation.

KW - Osteosarcoma cells

KW - Oxgen antioxidant

UR - http://www.scopus.com/inward/record.url?scp=0031812110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031812110&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 1175

EP - 1180

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 2 A

ER -